Bone regeneration for alveolar bone regeneration using platelet rich plasma

Bone regeneration for alveolar bone regeneration using platelet rich plasma - Bone regeneration for alveolar bone regeneration using platelet rich plasma

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000012596

Enrollment

Registered

2013-12-16

Start date

2012-03-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bone defect

Interventions

The autogenous venous blood collected from the patient to be centrifuged to concentrate the platelet rich plasma (=PRP). PRP with the autogenous bone is grafted for the surgical site.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patient for alveolar bone augmentation.

Exclusion criteria

Exclusion criteria: none

Design outcomes

Secondary

Measure	Time frame
1. The surgical site At 3, 7 and 30 days after surgery, we evaluate the surgical site as followed subjects. 1: good, 2: normal, 3: delay. 2. The postoperative infection 1: good, 2: normal, 3: bad. 3. The postoperative bone formation (with radiographic examination) The height and width measurment 4. The initial osseointegration 1: good, 2: normal, 3: poor.	—

Primary

Measure	Time frame
At 3, 7 and 30 days after surgery, we evaluate the surgical site in accordance with 1: good, 2: normal, 3: delay.	—

Countries

Japan

Contacts

Public ContactYuichi Itto

OsakaMedoical College Dept. of Oral Surgery and Dentistry

ora059@poh.osaka-med.ac.jp072-683-1221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026